Overview

Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects

Status:
Completed
Trial end date:
2020-09-11
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and pharmacokinetic profiles of HHT201 in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
Treatments:
Donepezil